T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers.

The discovery positions IGF2BP3 as a "master switch" in leukaemia, linking metabolism and RNA regulation, processes long ...

Race Oncology has achieved a breakthrough with its lead candidate RC220, uncovering the primary mechanism of action of its ...

Jessica Katawick's whole life changed on a September morning in 2020. "As soon as my feet hit the floor something said I should just do a breast exam today. I just knew it was breast cancer," said ...

There’s a lot of myths that we hear out there, and it’s time to separate the myths from the facts," Ostendorf-Morris said.

The drug, Zepzelca, in combination with Roche's Tecentriq, is approved for patients with extensive-stage small cell lung ...

In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and ...

UCSF researchers are advancing care through scientific breakthroughs that pave the way for less addictive pain medications ...

WJAC provides news, weather and sports information for Johnstown, Altoona, State College and DuBois, Pennsylvania. Our coverage area includes Bedford, Everett, Somerset, Meyersdale, Ebensburg, Windber ...

A genetic risk score could one day help women with DCIS or LCIS know if they are high or low risk and decide which treatment ...

Community MD Anderson Cancer Center launched its stem cell transplant program in 2024, admitting its first patients in the ...

The FDA has approved Zepzelca with Tecentriq or Tecentriq Hybreza for extensive-stage small cell lung cancer.